Home › Research › Prevention trials
The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: study protocol for a randomized controlled trial
Yi Ye, Qing Chen, Ruixuan Li, Xiaoyi Wang, Yueling Sun, Fangjiang Li, Xiaoping Liu, Le Wang et al.. Trials, 2025-02-21
Topic: Risk, prevention and care in population studies
COG-T CHD is the first clinical trial to evaluate the efficacy of computer-based cognitive training in patients with coronary heart disease, filling an important gap in the treatment evidence for cognitive digital therapy. TRIAL REGISTRATION: ClinicalTrials.gov, NCT05735041. Registered on Jan. 18, 2023.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ye, Y., Chen, Q., Li, R., Wang, X., Sun, Y., Li, F., et al. (2025). The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: study protocol for a randomized controlled trial. Trials. https://doi.org/10.1186/s13063-025-08745-6
Vancouver
Ye Y, Chen Q, Li R, Wang X, Sun Y, Li F, et al. The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: study protocol for a randomized controlled trial. Trials. 2025. doi:10.1186/s13063-025-08745-6. PMID: 39985041.
BibTeX
@article{ye2025-39985041,
author = {Ye, Yi and Chen, Qing and Li, Ruixuan and Wang, Xiaoyi and Sun, Yueling and Li, Fangjiang and Liu, Xiaoping and Wang, Le and others},
title = {{The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: study protocol for a randomized controlled trial}},
journal = {Trials},
year = {2025},
doi = {10.1186/s13063-025-08745-6},
pmid = {39985041},
url = {https://doi.org/10.1186/s13063-025-08745-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- COG-T CHD is the first clinical trial to evaluate the efficacy of computer-based cognitive training in patients with coronary heart disease, filling an important gap in the treatment evidence for cognitive digital therapy.
- TRIAL REGISTRATION: ClinicalTrials.gov, NCT05735041.
Why it matters
This paper describes the protocol for a randomized controlled trial testing computerized cognitive training in patients with coronary heart disease and cognitive impairment. No results are reported yet, so it cannot show whether the training is effective.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designrandomized controlled trial
- Evidence strengthHigh
How this study scored 47/100
Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for sample size, effect reported and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Trials) |
| Journal's citation record | 1 / 4 | Trials: journal h-index 132 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomised controlled trial |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 1 / 2 | Randomised (as stated in the record) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Yong Zeng: h-index 4 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Capital Medical University: institution h-index 643 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39985041) |
| Free to read | 2 / 2 | Free to read |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention trials
Also tagged “controlled”
1,118 studies in the library carry the topic tag “controlled”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,118 tagged studies.